FDA Label for Blood Clotting First Aid

View Indications, Usage & Precautions

Blood Clotting First Aid Product Label

The following document was submitted to the FDA by the labeler of this product Unifirst First Aid Corporation. The document includes published materials associated whith this product with the essential scientific information about this product as well as other prescribing information. Product labels may durg indications and usage, generic names, contraindications, active ingredients, strength dosage, routes of administration, appearance, warnings, inactive ingredients, etc.

Active Ingredients



Benzethonium Chloride 0.2% w/w
Lidocaine 4% w/w 


Purpose



Topical antiseptic
Topical anesthetic 


Uses



for help in control of superficial bleeding
for temporary relief of pain and to help protect against infection in minor cuts, scrapes, and burns 


Warnings



For external use only

Flammable
keep away from fire or flame
contents under pressure
do not puncture or incinerate container
do not expose to temperatures above 120° F 


Do Not Use



in or near eyes or other mucus membranes
in case of serious burns
in case of deep or puncture wounds
for a prolonged period of time
on a large portion of the body
on raw surfaces
on blistered areas 


Stop Use And Ask A Doctor If



condition worsens or symptoms persist for more than 7 days
condition clears up and recurs within a few days
redness, swelling, or irritation occurs 


Directions



clean the affected area
shake can well before using
hold 6-8 inches from surface
spray until area is covered and superficial bleeding is stopped
scab-like cover will gradually disappear or may be removed with soap and water
for adult institutional use only
not intended for use on children 


Other Information



avoid inhaling
use only as directed
intentional misuse by deliberately concentrating and inhaling the contents may be harmful or fatal 


Inactive Ingredients



isobutane, isopropyl myristate, karaya, n-butane, propane, silica, sorbitan monooloate, talc, tragacanth.


* Please review the disclaimer below.